Cargando…
Preclinical Characterization of Antioxidant Quinolyl Nitrone QN23 as a New Candidate for the Treatment of Ischemic Stroke
Nitrones are encouraging drug candidates for the treatment of oxidative stress-driven diseases such as acute ischemic stroke (AIS). In a previous study, we found a promising quinolylnitrone, QN23, which exerted a neuroprotective effect in neuronal cell cultures subjected to oxygen–glucose deprivatio...
Autores principales: | Martínez-Alonso, Emma, Escobar-Peso, Alejandro, Aliena-Valero, Alicia, Torregrosa, Germán, Chioua, Mourad, Fernández-Serra, Rocío, González-Nieto, Daniel, Ouahid, Youness, Salom, Juan B., Masjuan, Jaime, Marco-Contelles, José, Alcázar, Alberto |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9220178/ https://www.ncbi.nlm.nih.gov/pubmed/35740081 http://dx.doi.org/10.3390/antiox11061186 |
Ejemplares similares
-
Neuroprotective and Antioxidant Properties of CholesteroNitrone ChN2 and QuinolylNitrone QN23 in an Experimental Model of Cerebral Ischemia: Involvement of Necrotic and Apoptotic Cell Death
por: Chamorro, Beatriz, et al.
Publicado: (2023) -
Characterization of a CholesteroNitrone (ISQ-201), a Novel Drug Candidate for the Treatment of Ischemic Stroke
por: Martínez-Alonso, Emma, et al.
Publicado: (2020) -
Improving the Efficacy of Quinolylnitrones for Ischemic Stroke Therapy, QN4 and QN15 as New Neuroprotective Agents after Oxygen–Glucose Deprivation/Reoxygenation-Induced Neuronal Injury
por: Alonso, José M., et al.
Publicado: (2022) -
Homo-Tris-Nitrones Derived from α-Phenyl-N-tert-butylnitrone: Synthesis, Neuroprotection and Antioxidant Properties
por: Diez-Iriepa, Daniel, et al.
Publicado: (2020) -
Melatonin and Nitrones As Potential Therapeutic Agents for Stroke
por: Romero, Alejandro, et al.
Publicado: (2016)